[ET Net News Agency, 5 March 2024] REMEGEN (09995) fell 9.5% to HK$21.95, dipping below
the 10-D SMA of HK$22.08.
It hits an intra-day low of HK$21.7, and an intra-day high of HK$24.1. The total shares
traded was 4.56 million, with a value of HK$104.13m. The active buy/sell ratio is 40:60,
with net selling turnover of HK$21m. MORGAN STANLEY HK SEC accounts for greatest net
responsive buying turnover of HK$13.16m, with volume weighted average price of HK$22.88.
CHINA INV INFO accounts for greatest net responsive selling turnover of HK$5.13m, with
volume weighted average price of HK$22.802.

Basic Information
=================

----------------------------------
Nominal 21.950 % Chg -9.48%
High 24.100 Low 21.700
Shares Tr 4.56m Turnover 104.13m
10-D SMA 22.080 %H.V 90.212
20-D SMA 19.991 VWAP 22.836
50-D SMA 24.809 RSI14 49.997
----------------------------------
Status: Dipping below the 10-D SMA, active buy/sell ratio is 40:60, with net selling
turnover of HK$21m

Performance of stocks in the same sector or of relevance
========================================================

Stock (Code) Price (HK$) Change (%)
---------------------------------------------
REMEGEN (09995) 21.95 -9.48
HUTCHMED (00013) 22.40 -8.01
GENSCRIPT BIO (01548) 14.94 -5.32
INNOVENT BIO (01801) 39.25 -5.88
EVEREST MED-B (01952) 23.70 -3.46
WUXI XDC (02268) 22.40 -3.86
WUXI BIO (02269) 19.98 -4.86
BEIGENE (06160) 97.55 -1.86
SKB BIO-B (06990) 118.00 -1.67
AKESO (09926) 45.35 -4.73
---------------------------------------------
(ed)